CDK2 inhibitors

NOVEL COMPOUNDS

Indole compounds and analogues thereof

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

Protein and peptide purification methods

ACYLSUFONAMIDE COMPOUNDS USEFUL AS EP3 RECEPTOR ANTAGONISTS

Selective ligands for modulation of GIRK channels

Inhibitors of prolyl-tRNA-synthetase

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

Inhibition of Olig2 activity

C-met modulators and methods of use

ErbB/BTK inhibitors

Nuclear transport modulators and uses thereof

Triazine Compounds and Uses Thereof

SOLID FORMS OF APOL1 INHIBITOR AND METHODS OF USING SAME

Substituted pyrimidinones as agonists of the APJ receptor

ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF

SMALL MOLECULE MODULATORS OF PANTOTHENATE KINASES

Deuterated Defactinib compound and use thereof

Compounds for the modulation of cyclophilins function

SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS

Compounds and Their Use for Reducing Uric Acid Levels

Thyroid hormone receptor agonists and use thereof

Tetrahydroindazoles and medical uses thereof

Compounds with tubulin polymerisation inhibitory activity and immunomodulatory properties

INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE

Antibacterial compounds

Pyridine and pyrazine derivative for the treatment of chronic bronchitis

Process for making beta 3 agonists and intermediates

Pyrimidine derivative, method for preparing same and use thereof in medicine

AMORPHOUS FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION

ISATIN DERIVATIVES

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

Pharmaceutical combination, composition and compound preparation containing glucokinase activator and K-ATP channel blocker, preparation method therefor and use thereof

Pyrimidine compound as JAK kinase inhibitor

Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and SGLT-2 inhibitor and preparation methods and uses thereof

Amide compounds and method for making and using

1,3-dipolar cycloadditions, and Staudinger ligations for conjugating biomolecules using click chemistry

NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

Pharmaceutical combination containing glucose kinase activator and PPAR receptor activator, composition, compound preparation method for same, and uses thereof

COMPOUND FOR REGULATING GENE EDITING EFFICIENCY AND APPLICATION THEREOF

Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan

Pyridinyl and pyrazinyl-(asa)indolsulfonamides

Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-D3) pyridazine-3-carboxamide

Methods for the manufacture of an aromatic bisimide and a polyetherimide

Nitrogen-containing compound, electronic element and electronic device

Sulfonyl-structure-containing triazinone derivatives, their preparation methods and their uses in insect killing and/or bacterium killing

AXL kinase inhibitors and use of the same

AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS

SMYD INHIBITORS

Heterocyclic compounds for the inhibition of PASK

Compound for organic electric element, organic electric element comprising the same, and electronic device thereof

Therapeutic compounds and compositions

Non-aggregating heptamethine cyanine fluorophores for in vivo imaging

Pharmaceutical combination and composition, and combination preparation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereof

Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and DPP-IV inhibitor, and preparation method and use thereof

Methods and compositions useful in treating cancer and reducing WNT mediated effects in a cell

Antagonists of the muscarinic acetylcholine receptor M4

OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISORDERS AND SKIN DISEASES

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

Potassium channel inhibitors

Proteasome activity enhancing compounds

Cannabinoid receptor modulators

Drug-conjugates, conjugation methods, and uses thereof

Glycosidase inhibitors

Diaminotriazine compounds

3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

Heterocyclic compound

MASP-2 inhibitors and methods of use

NEW COMPOUNDS FOR USE AS A THERAPEUTICALLY ACTIVE SUBSTANCE AND IN PARTICULAR FOR USE IN THE TREATMENT OF TUMORS

Tetrazolinone compounds and its use

Benzenesulfonamide compouds and their use as therapeutic agents

MASP-2 inhibitors and methods of use

Substituted pyrazole-pyrimidines, variants thereof, and uses therefore

Purified cenicriviroc and purified intermediates for making cenicriviroc

GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF

Methods and composition of 4-substituted benzoylpiperazine-1-substituted carbonyls as beta-catenin/B-cell lymphoma 9 inhibitors

Glycolate oxidase inhibitors for the treatment of disease

Alpha-5 beta-1 inhibitors

1,4-disubstituted imidazole derivative

OX2R compounds

EP4 antagonist

Carbamate and urea compounds as multikinase inhibitors

Kinase inhibitors for the treatment of central and peripheral nervous system disorders

Cycloolefin substituted heteroaromatic compounds and their use

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

Inhibitors of Rho associated coiled-coil containing protein kinase

Methods of synthesizing thyroid hormone analogs and polymorphs thereof

Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof

Tryptophan hydroxylase inhibitor and pharmaceutical composition including same

CARM1 INHIBITORS AND USES THEREOF

THE SALTS OF A COMPOUND AND THE CRYSTALLINE FORMS THEREOF

Iridinesulfonamide compound and use method thereof

QUINAZOLINE COMPOUND SERVING AS EGFR TRIPLE MUTATION INHIBITOR AND APPLICATIONS THEREOF

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS

Reversible linkers and use thereof

Inhibitors of receptor interacting protein kinase I for the treatment of disease

Modulators of eukaryotic initiation factor 2B, compositions and methods

5-membered and bicyclic heterocyclic amides as inhibitors of rock

Cardiac sarcomere inhibitors

Synthesis of cerdulatinib

RHO KINASE INHIBITORS

Benzimidazolone derived inhibitors of BCL6

Immunomodulator compounds

Hypocrellin derivative substituted both in a peri-position and in 2-position by amino, preparation method, and application thereof

MODULATORS OF CELLULAR ADHESION

Pyridine and pyrazine compounds

PIKfyve inhibitors

Compounds and uses thereof

Radiotracer Derivatives Of Trimethoprim For Diagnostic Imaging

3,5-disubstituted pyrazoles useful as checkpoint kinase 1 (Chk1) inhibitors, and their preparations and applications

Inhibitors of cyclin-dependent kinases

Compounds for use in synthesis of peptidomimetics

Solid forms of Cerdulatinib

Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

Compounds useful as inhibitors of isoprenylcysteine carboxyl methyltransferase

Photocleavable nitroindoline-based crosslinkers

Aminopyrimidine amide autophagy inhibitors and methods of use thereof

SOLID FORMS OF 2-(3,5-DICHLORO-4-((5-ISOPROPYL-6-OXO-1,6-DIHYDROPYRIDAZIN-3-YL)OXY)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBONITRILE

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

Amino compounds for treatment of immune and inflammatory disorders

ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION

Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

Adhesive composition for semiconductor circuit connection and adhesive film containing the same

Amido compounds as AhR modulators

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

INHIBITION OF OLIG2 ACTIVITY

Indole derivatives and their use as protein kinase inhibitors

Elimination of hepatitis b virus with antiviral agents

Pyrimidine derivatives as PGE2 receptor modulators

Light-emitting element, display device, electronic device, and lighting device

OX2R compounds

Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl- D3)pyridazine-3-carboxamide

Indole carboxamide compounds

Urea derivative or pharmacologically acceptable salt thereof

BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF

Substituted benzenecarboxamides as IL-17A modulators

2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors

Heptamethine cyanines for use as fluorescent markers of the biliary and renal systems

Heterocyclic compounds and uses as anticancer agents

Inhibitors of receptor interacting protein kinase I for the treatment of disease

Antimalarial hexahydropyrimidine analogues

Carboxamide compounds and uses thereof

Pyrimidine compounds useful as tyrosine kinase inhibitors

Inhibitors of receptor interacting protein kinase I for the treatment of disease

INHIBITORS OF EGFR AND METHODS OF USE THEREOF

Indole derivatives as efflux pump inhibitors

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

Compounds as nuclear transport modulators and uses thereof

Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

Crystalline Form II of Darolutamide

Aryl and heteroaryl substituted indole compounds

FACTOR XIIa INHIBITORS

NEUROTENSIN RECEPTOR LIGANDS

MTA-cooperative PRMT5 inhibitors

MTA-cooperative PRMT5 inhibitors

Triazacyclododecansulfonamide (“TCD”)-based protein secretion inhibitors

QUINAZOLINE DERIVATIVE AND USE THEREOF

SUBSTITUTED PYRIMIDINES FOR TREATING BACTERIAL INFECTIONS

Human plasma kallikrein inhibitors

Therapeutic compounds and methods of use thereof

2-substituted pyrazole amino-4-substituted amino-5-pyrimidine formamide compound, composition, and application thereof

Reagents and methods for analysis of proteins and metabolites targeted by covalent probes

Apelin receptor (APJ) agonists and uses thereof

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

Substituted indole ether compounds

Heterocyclic RIP1 kinase inhibitors

RIP1 inhibitory compounds and methods for making and using the same

2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

Anti-inflammatory agents

Pharmaceutically Active Compounds

INTEGRIN TARGETING LIGANDS AND USES THEREOF

DNA-PK inhibitors

7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same

Reactive oxygen species scavengers and use for treating diseases

5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same

P300/CBP hat inhibitors

Substituted benzamides

Nitrogen-containing heteroaryl compounds and methods of use thereof

Workflow for generating compounds with biological activity against a specific biological target

Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof

Inhibitors of protein arginine deiminases

Inhibitors of cyclin-dependent kinases

Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof

Pyrazole MAGL inhibitors

Fused imidazole derivatives as IL-17 modulators

Acryloyl-containing nuclear transport regulators and uses thereof

Salt of a quinazoline derivative-like tyrosine kinase inhibitor and crystal form thereof

Heterocyclic compounds as pesticides

Modulators of cystic fibrosis transmembrane conductance regulator

2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same

Hetero ring-fused phenyl compounds for inhibiting TNIK and medical uses thereof

Compounds for the treatment of parasitic infections

Human plasma kallikrein inhibitors

Human plasma kallikrein inhibitors

Lanthionine synthetase C-like 2-based therapeutics

Methods and compositions associated with the granulocyte colony-stimulating factor receptor

pH sensitive dyes for textile materials, a process for their preparation and uses thereof

FUSED RING HETEROARYL COMPOUNDS AS RIPK1 INHIBITORS

Compounds for the treatment of kinase-dependent disorders

Indole derivatives as estrogen receptor degraders

Solid forms of an HPK1 inhibitor

DACOS type NNRTIS amino acid ester derivative, preparation method thereof, pharmaceutical composition, and application thereof

Modulators of Rho-associated protein kinase

PSMA Imaging Agents

Cyanoindoline derivatives as NIK inhibitors

Compounds and their use as PDE4 activators

PSMA imaging agents

Compounds as modulators of TLR2 signaling

Compounds

4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication

Dimeric contrast agents

Pyrimidine derivatives for the treatment of viral infections

PHARMACOKINETICALLY IMPROVED COMPOUNDS

AHR inhibitors and uses thereof

Antiviral benzodiazepine compounds

Heterocyclic compounds as pesticides

Theramutein modulators

Substituted pyrimidine compound and preparation method and use thereof

Amine derivative and an organic electroluminescent device thereof

Process for the preparation of pyrimidinyl-4-aminopyrazole compounds

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

Sulfonyldiazoles and N-(fluorosulfonyl)azoles, and methods of making the same

Theramutein modulators

Bicyclic compounds and their use in the treatment of cancer

N4-phenyl-quinazoline-4 -amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

Indazole compounds and uses thereof

CYANOPYRROLIDINES AS USP30 INHIBITORS AND FIBROSIS TREATMENT

Sulphonyl urea derivatives as NLRP3 inflammasome modulators

Compounds, compositions, and methods

Triazabutadienes as cleavable cross-linkers

PKM2 MODULATORS AND METHODS FOR THEIR USE

Substituted pyrimidines containing acidic groups as TLR7 modulators

Compositions and methods for treating infections

Compounds for the treatment of BRAF-associated diseases and disorders

BRD4-kinase inhibitors as cancer therapeutics

Tead inhibitors and uses thereof

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

THRB receptor agonist compound and preparation method and use thereof

Pyrimidinone-containing compound, preparation method thereof, pharmaceutical composition and application thereof

Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

Unusually potent ABA receptor pan-antagonists

Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof

Substituted pyrrolidine compound and use thereof

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

Indazole derivatives and pharmaceutical composition for preventing, alleviating or treating cancer containing the same

Antagonists of the muscarinic acetylcholine receptor M4

Substituted heterocycles as c-MYC targeting agents

Method for producing bispyrrolidine compounds

NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF

NEW BENZIMIDAZOLES DERIVATIVES AS TEC KINASES FAMILY INHIBITORS

Substituted pyrrolidine compound and use thereof

Triaryl compounds for treatment of PD-L1 diseases

PSMA imaging agents

Bicyclic-fused heteroaryl or aryl compounds

BENZIMIDAZOLES AND AZA-BENZIMIDAZOLES, AND METHODS OF USE THEREOF

DEGRADERS OF EGFR AND METHODS OF USE THEREOF

Inhibitors

SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS

Pigment dispersing agent, pigment composition, and pigment coloring agent

Inhibitors of APOL1 and methods of using same

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

IP6K inhibitors

Anti-cancer azole compounds

Fused thiophene derivatives and their uses

Materials for organic electroluminescent devices

Pyrimidine compound as JAK kinase inhibitor

Compounds

Antagonists of the muscarinic acetylcholine receptor M

Autophagy modulators for use in treating cancer

N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOSTERIC MODULATORS OF NR2B

Fused thiophene derivatives and their uses

SUBSTITUTED BENZENE AND 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS

Nitrogen-containing benzoheterocycle compound comprising carboxylic acid group, preparation method and use thereof

NLRP3 inflammasome inhibitors

NLRP3 inflammasome inhibitors

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

Quinoxalinone compounds, compositions, methods, and kits for increasing genome editing efficiency

Process for the preparation of drug linker compounds

Anti-cancer nuclear hormone receptor-targeting compounds

Quinazoline compounds

Heteroaryl inhibitors of PDE4

Biocompatible modular tetrazine platform

Quinoxaline derivatives as adenosine receptor antagonists

Hsp90 inhibitors and uses thereof

Processes to produce acalabrutinib

Benzenesulfonamide compounds and their use as therapeutic agents

Modulators of THR-β and methods of use thereof

Compounds for use in synthesis of peptidomimetics

Heterocyclic inhibitors of tyrosine kinase

2-(1H-pyrazol-3-yl) phenol compound and use thereof

Sulfonamide carboxamide compounds

Substituted pyridines as TYK2 inhibitors

Small molecule agonists of neurotensin receptor 1

Thiosemicarbazates and uses thereof